NCT06154434

Bioequivalence Study in Healthy Subjects by Using of Chlorpromazine HCl 100mg Tablets

An Open Label, Randomized, Fasting, Single-dose, Two-period Crossover Study to Compare the Bioequivalence of Chlorpromazine HCl 100mg Tablets After Oral Administration in Healthy Subjects.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 70 (actual)
• Sponsor: Whanin Pharmaceutical Company · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

This clinical study is an open label, randomized, fasting condition, single-dose, two-period crossover study to compare the bioequivalence of Chlorpromazine HCl 100mg Tablets after oral administration in healthy subjects.

Conditions

• Healthy Subject

Interventions

Type	Name	Description
DRUG	Chlorpromazine HCl 100mg Tablets	single-dose administered after a 10-hour overnight fast.

Timeline

• Start date: 2018-12-06
• Primary completion: 2019-02-12
• Completion: 2019-02-12
• First posted: 2023-12-04
• Last updated: 2023-12-08

Locations

1 site across 1 country: South Korea